Factsheet data is now cached locally - if you have visited a page you can now view it offline!
Are you a harm reduction organisation using TripSit? Let us know about you!
4-HO-MPMI
Basic Information
Summary
A rare tryptamine derivative first synthesised by David Nichols. This drug, also known as lucigenol, has rarely been documented outside the lab. It is known to be a psychedelic similar to other psychoactive tryptamines, with a potency similar to DOI, but little else is known.
Psychedelic
Psychedelics are drugs which alter the perception, causing a number of mental effects which manifest in many forms including altered states of consciousness, visual or tactile effects.
Read more on TripSit Wiki...Research Chemical
Research chemicals are drugs with relatively little history of human use, and thus particular care should be taken if choosing to ingest them.
Read more on TripSit Wiki...Tentative
Drugs marked as tentative are those our team wasn't able to find much reliable information about. This is often because the drug is very new. Information listed under these drugs should not be entirely trusted.
Dose
Oral | |
---|---|
Threshold | 500-750ug. |
Light | 750ug-1mg |
Common | 1-2mg. |
Note, this substance has never been reported on past 2mg's. Use you're judgement; It's near eqipotent to DOI.
Duration
All ROAs | |
---|---|
Onset | 15-60 minutes |
Duration | 6-8 hours |
Aliases
lucigenol
Effects
Euphoria, empathy, insight, brightened colour, Closed/Open eye visuals, enhanced tactile sensation, mental/physical stimulation, decreased appetite, pupil dilation, restlessness, change in perception, ego softening, sweating/chills, muscle tension, confusion, insomnia.
Interactions
No interaction information for 4-HO-MPMI